The COVID-19 pandemic has impacted the number of people seeking and receiving care for TB, eroding gains made in the fight against TB. COVID-19 has exposed weaknesses and inequities in health care delivery in many countries, driving many people into poverty. Patient-centered care services for TB are more essential than ever because it is “respectful of and responsive to individual patient preferences, needs, and values, and ensuring that patient values guide all clinical decisions.” COVID-19 presents opportunities for adapting strategies and leveraging upon innovative approaches and technology to strengthen the delivery of health care services.
Join us for a conversation with FHI 360 and other TB experts to learn more about:
• USAID new strategies for TB and patient-centered care approaches: Dr. Paul Pierre, USAID Washington
• TB preventive therapy and going to scale: Mpande Mukumbwa-Mwenechanya, Centre for Infectious Disease Research, Zambia
• Differentiated service delivery and TB treatment – lessons learned: Dr. Cuc Hong Tran, CDC, Atlanta
• Experiences from the field on patient-centered TB care during COVID-19: Merry Samsuri, FHI 360, Indonesia and Mary Rosary Santiago, FHI 360, Philippines
Dr. Farai Mavhunga from the World Health Organization in Geneva will moderate the panel and Q&A discussion on global approaches in COVID-19 era and moderation.
Dr. Christian Pitter, FHI 360, will provide the closing remarks.